CWM
ARLZ

Circle Wealth Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Circle Wealth Management’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-24,824
Closed -$34K – 90
2017
Q2 		$34K Sell
24,824
-7,028
-22% -$10.2K 0.02% 83
2017
Q1 		$68K Hold
31,852
– – 0.03% 76
2016
Q4 		$140K Buy
+31,852
New +$151K 0.07% 67

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
BAS
Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return

Circle Wealth Management's ARLZ Position: Q3 2017 in Review

Circle Wealth Management sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2017, closing a stake of 24,824 shares — an estimated $34K sold.

Circle Wealth Management first reported a position in ARLZ in Q4 2016 and held it in 3 quarters. The position peaked at $140K in Q4 2016. 59 funds tracked by Wall St. Rank hold ARLZ as of Q3 2017.

  • Circle Wealth Management reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2017 after selling out during the quarter.
  • Circle Wealth Management sold 24,824 Aralez Pharmaceuticals Inc. shares in Q3 2017, an estimated $34K.
  • Circle Wealth Management first reported a position in Aralez Pharmaceuticals Inc. in Q4 2016 and held it in 3 quarters.
  • Circle Wealth Management's Aralez Pharmaceuticals Inc. position peaked at $140K in Q4 2016.
  • 59 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2017.

Based on Circle Wealth Management's 13F filing for Q3 2017, filed 14 Nov 2017.